Note 7 - Long-term Debt	6 Months Ended
Jun. 30, 2018
Notes to Financial Statements
Long-term Debt [Text Block]	NOTE 7: LONG-TERM DEBT The Company has a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to $7 million, although the Company has never utilized this facility. This credit facility remains available until September 1, 2018 at which time we expect it to be renewed. The credit facility also contains certain financial covenants, all of which the Company was in compliance with at June 30, 2018 and December 31, 2017. The Company has a loan agreement with HSBC which is secured by a mortgage against our facility at 355 South Technology Drive, Central Islip, NY. The loan is payable in 120 consecutive equal monthly installments of principal of $25,000 plus interest thereon and a final balloon payment upon maturity in March 2022. The balances on the mortgage at June 30, 2018 and December 31, 2017 were approximately $2.8 and $3.0 million, respectively. Interest accrues on the loan, at the variable rate of LIBOR plus 1.75%, which was 3.84% and 3.31% at June 30, 2018 and December 31, 2017, respectively. The Company has an additional loan agreement with HSBC which is secured by a mortgage against our facility at 555 North Research Place, Central Islip, New York. The loan is payable in 60 consecutive monthly installments of approximately $63,000 including interest. Interest accrues on the loan at the fixed rate of 3.91%. The maturity date for the Note is December 1, 2022. The outstanding principal balances as of June 30, 2018 and December 31, 2017 were approximately $10.2 million and $10.4 million, respectively. We are uncertain as to whether or not we will be able to maintain compliance with our Fixed Charge Coverage Ratio Covenant as of September 30, 2018. We intend to enter into discussions with our lender to either amend the covenant or if applicable, obtain a waiver of any such covenant default. However, there can be no assurance that we will be able to obtain such amendment or waiver on commercially reasonable terms, the failure of which could have a material adverse effect on our financial condition.

NOTE

LONG-TERM DEBT

The Company has a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to

million, although the Company has never utilized this facility. This credit facility remains available until

September 1, 2018

at which time we expect it to be renewed. The credit facility also contains certain financial covenants, all of which the Company was in compliance with at

June 30, 2018

and

December 31, 2017.

The Company has a loan agreement with HSBC which is secured by a mortgage against our facility at

355

South Technology Drive, Central Islip, NY. The loan is payable in

120

consecutive equal monthly installments of principal of

$25,000

plus interest thereon and a final balloon payment upon maturity in

March 2022.

The balances on the mortgage at

June 30, 2018

and

December 31, 2017

were approximately

$2.8

and

$3.0

million, respectively. Interest accrues on the loan, at the variable rate of LIBOR plus

1.75%,

which was

3.84%

and

3.31%

June 30, 2018

and

December 31, 2017,

respectively.

The Company has an additional loan agreement with HSBC which is secured by a mortgage against our facility at

555

North Research Place, Central Islip, New York. The loan is payable in

consecutive monthly installments of approximately

$63,000

including interest. Interest accrues on the loan at the fixed rate of

3.91%.

The maturity date for the Note is

December 1, 2022.

The outstanding principal balances as of

June 30, 2018

and

December 31, 2017

were approximately

$10.2

million and

$10.4

million, respectively.

We are uncertain as to whether or

not

we will be able to maintain compliance with our Fixed Charge Coverage Ratio Covenant as of

September 30, 2018.

We intend to enter into discussions with our lender to either amend the covenant or if applicable, obtain a waiver of any such covenant default. However, there can be

assurance that we will be able to obtain such amendment or waiver on commercially reasonable terms, the failure of which could have a material adverse effect on our financial condition.